newsfilter
← Latest News
ACCESS Newswire·

Relief Therapeutics Appoints Christopher Wick as Senior Director, Head of U.S. Sales

Proven Pharmaceutical Sales Professional Brings Big Pharma Experience to Relief's U.S. Expansion Activities GENEVA, SWITZERLAND / ACCESSWIRE / March 21, 2022 / RELIEF THERAPEUTICS Holding SA ((SIX: RLF, OTCQB:RLFTF, RLFTY)) (" Relief "), a biopharmaceut